Lemaitre Vascular (LMAT) Profit Margin (2010 - 2026)
Lemaitre Vascular (LMAT) profit margin from Jun 30, 2010 to Mar 31, 2026. The current Lemaitre Vascular (LMAT) profit margin is 23.56%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Lemaitre Vascular (LMAT)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 23.13% | +15.47% |
| 2024 | 20.03% | +357.57% |
| 2023 | 4.38% | +25.69% |
| 2022 | 3.48% | -75.10% |
| 2022 | 13.99% | +67.35% |
| 2022 | 8.36% | -45.25% |
| 2022 | 15.27% | +281.50% |
| 2021 | 4.00% | -76.38% |
| 2021 | 16.94% | -16.99% |
| 2021 | 20.41% | +23.48% |
| 2021 | 16.53% | +0.76% |
| 2020 | 16.40% | -20.46% |
| 2020 | 20.62% | +46.41% |
| 2020 | 14.08% | +35.74% |
| 2020 | 10.38% | -32.16% |
| 2019 | 15.29% | -14.08% |
| 2019 | 17.80% | +13.59% |
| 2019 | 15.67% | +27.16% |
| 2019 | 12.32% | -43.28% |
| 2018 | 21.73% | +21.86% |
| 2018 | 17.83% | -44.93% |
| 2018 | 32.38% | +118.61% |
| 2018 | 14.81% | -13.03% |
| 2017 | 17.03% | -16.13% |
| 2017 | 20.31% | +12.93% |
| 2017 | 17.98% | +34.80% |
| 2017 | 13.34% | +12.29% |
| 2016 | 11.88% | -14.60% |
| 2016 | 13.91% | +19.79% |
| 2016 | 11.61% | +8.42% |
| 2016 | 10.71% | +8.14% |
| 2015 | 9.90% | +79.64% |
| 2014 | 5.51% | +11.21% |
| 2013 | 4.96% | +9.45% |
| 2012 | 4.53% | +22.10% |
| 2011 | 3.71% | -65.40% |
| 2010 | 10.72% | +241.12% |
| 2009 | 3.14% | N/A |
Comparison Lemaitre Vascular (LMAT) profit margin with competitors
Lemaitre Vascular (LMAT) profit margin is 23.56%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| DXR | Daxor Corp | 34359.00% | +145728.54% |
| NNNN | Anbio Biotechnology - Class A | 74.06% | +214.33% |
| UTMD | Utah Medical Products Inc | 29.86% | +26.73% |
| ISRG | Intuitive Surgical Inc | 29.65% | +25.84% |
| RMD | Resmed Inc | 27.86% | +18.25% |
| PDEX | Pro-Dex Inc (co) | 19.74% | -16.22% |
| HOLX | Hologic Inc | 17.09% | -27.47% |
| WST | West Pharmaceutical Services Inc | 16.43% | -30.27% |
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 11.19% | -52.51% |
| ALGN | Align Technology Inc | 10.84% | -53.99% |
| MMSI | Merit Medical Systems Inc | 10.74% | -54.42% |
| STVN | Stevanato Group Spa | 10.25% | -56.50% |
| ATR | Aptargroup Inc | 7.39% | -68.63% |
| ALC | Alcon Inc | 6.98% | -70.38% |
| ZJYL | Jin Medical International Ltd | 5.76% | -75.55% |
| ICUI | ICU Medical Inc | 5.68% | -75.89% |
| STAA | Staar Surgical Company | 5.57% | -76.36% |
| NVST | Envista Holdings Corp | 5.49% | -76.70% |
| BLFS | Biolife Solutions Inc | 4.31% | -81.71% |
| RGEN | Repligen Corp | 4.29% | -81.79% |
| AVTR | Avantor Inc | 2.74% | -88.37% |
| NEPH | Nephros Inc | 2.69% | -88.58% |
| SMTI | Sanara MedTech Inc | 1.65% | -93.00% |
| WRBY | Warby Parker Inc - Class A | 1.31% | -94.44% |
| SOLV | Solventum Corp | 0.65% | -97.24% |
| ATRC | Atricure Inc | 0.08% | -99.66% |